检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:董爱丽 Dong Aili(General Practice Department,Beijing Fangshan District Dashiwo Town Community Health Service Center 102408,Beijing,China)
机构地区:[1]北京市房山区大石窝镇社区卫生服务中心全科,北京102408
出 处:《中外医药研究》2025年第4期45-47,共3页JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH
摘 要:目的:对比缬沙坦分别联合氨氯地平和氢氯噻嗪治疗老年高血压的效果。方法:选择2022年10月—2023年10月北京市房山区大石窝镇社区卫生服务中心收治的86例老年高血压患者作为研究对象,以随机数字表法分为对照组和试验组,各43例。对照组应用缬沙坦联合氢氯噻嗪治疗,试验组应用缬沙坦联合氨氯地平治疗。对比两组血压水平及不良反应发生率。结果:治疗前,两组收缩压、舒张压水平对比,无统计学差异(P>0.05);治疗后,两组收缩压、舒张压水平下降,试验组低于对照组(P<0.05)。两组不良反应发生率对比,无统计学差异(P>0.05)。结论:缬沙坦联合氨氯地平治疗老年高血压的效果优于缬沙坦联合氢氯噻嗪,血压控制效果更佳,且未增加不良反应发生风险。Objective:To compare the effectiveness of valsartan combined with amlodipine versus hydrochlorothiazide in the treatment of elderly hypertension.Methods:A total of 86 elderly patients with hypertension treated at the Beijing Fangshan District Dashiwo Town Community Health Service Center,from October 2022 to October 2023 were selected as the study subjects.They were randomly divided into a control group and an experimental group,with 43 cases in each group.The control group was treated with valsartan combined with hydrochlorothiazide,while the experimental group was treated with valsartan combined with amlodipine.Blood pressure levels and the incidence of adverse reactions were compared between the two groups.Results:Before treatment,there was no significant difference in systolic and diastolic blood pressure levels between the two groups(P>0.05).After treatment,both groups showed a reduction in systolic and diastolic blood pressure levels,with the experimental group exhibiting lower levels than the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Valsartan combined with amlodipine is more effective in treating elderly hypertension than valsartan combined with hydrochlorothiazide,providing better blood pressure control without increasing the risk of adverse reactions.
分 类 号:R544.1[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145